Fierce Pharma
SEPTEMBER 3, 2024
Late last year, Novo Nordisk responded to a growing shortage of popular Ozempic with a plan to cut down on production of its older diabetes med Victoza to make room for more Ozempic. | The company and the European Medicines Agency warned European healthcare providers to continue limiting new patient prescriptions until the shortages let up.
MedCity News
SEPTEMBER 3, 2024
We must empower health plan members with culturally and linguistically-relevant information about their benefits and health – tools that in turn encourage them to adopt a proactive and informed approach to their well-being. The post Health Literacy Is Not a Multi-Language Insert appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
SEPTEMBER 3, 2024
Semnur Pharmaceuticals, which is working on a non-opioid prospect for sciatica, has agreed to merge with special purpose acquisition company Denali Capital Acquisition Corp. | Semnur Pharmaceuticals is following in its parent company Scilex's footsteps with a special purpose acquisition company (SPAC) merger.
pharmaphorum
SEPTEMBER 3, 2024
EU had no grounds to probe Illumina's takeover of Grail, says ECJ, but while spinoff has already taken place Illumina can now avoid a €432m fine
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
SEPTEMBER 3, 2024
Dr. Reddy’s has been cut off from China’s bulk-buy drug procurement program after an inspection turned up “serious defects” in the company’s manufacturing operations. | Following a remote inspection of a Dr. Reddy’s formulations production plant, China’s National Medical Products Administration has suspended the import, sale and use of the Indian drugmaker’s atomoxetine hydrochloride capsules for ADHD.
Pharmaceutical Commerce
SEPTEMBER 3, 2024
How can industry stakeholders ensure the quality and supply chain security of existing product?
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
SEPTEMBER 3, 2024
The European Union’s highest court sided with Illumina, agreeing that the European Commission had no authority to review the acquisition of liquid biopsy company Grail. The ruling comes after Illumina stopped challenging antitrust litigation, opting to instead spin out Grail as a standalone company. The post Illumina’s European Court Victory Can’t Salvage Grail Acquisition, But It Nullifies Hefty Fine appeared first on MedCity News.
Pharmaceutical Technology
SEPTEMBER 3, 2024
The UAE has partnered with Novo Nordisk Pharma Gulf to develop a national scientific guide for obesity management and weight control.
MedCity News
SEPTEMBER 3, 2024
As Gen AI continues to mature, there will be ways to employ these technologies thoughtfully and safely in healthcare today. The key is to continue to embrace new breakthroughs – with strong guardrails for safety, privacy and transparency. The post Eliminating the AI ‘Black Box’ to Make Clinical Data Usable appeared first on MedCity News.
Pharmaceutical Commerce
SEPTEMBER 3, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, highlights the hard-hitting points that she anticipated will be covered during her session at the 2024 HDA Traceability Seminar.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
SEPTEMBER 3, 2024
Sounder Benefits, which was built at Redesign Health, launched last week with $7.5 million in funding. The company is a health tech startup specializing in benefits for employers with fewer than 1,000 employees. The post Sounder Benefits Launches To Advance Employee Health Benefits appeared first on MedCity News.
Pharmaceutical Commerce
SEPTEMBER 3, 2024
The latest news for pharma industry insiders.
Pharmaceutical Technology
SEPTEMBER 3, 2024
In clinical supplies, the Importer of Record (IoR) provides a critical service in facilitating logistics and easing the burden for sponsors.
pharmaphorum
SEPTEMBER 3, 2024
A digital version of the NHS Health Check offered to older people in the UK will be piloted in some areas of England early next year, according to the government.The Department of Health and Social Care (DHSC) has said the digital alternative to the current system of in-person health checks will be ready for testing in early 2025, with pilots planned for Norfolk, Medway, and Lambeth in London.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmaceutical Technology
SEPTEMBER 3, 2024
There are currently no approved treatments that can halt or reverse photoreceptor degeneration in patients with retinitis pigmentosa.
pharmaphorum
SEPTEMBER 3, 2024
EU follows through on plan to revoke approval for Advanz Pharma's Ocaliva for rare disease primary biliary cholangitis (PBC)
PharmaVoice
SEPTEMBER 3, 2024
As the agency considers eliminating adcomm votes from the approval process, members vie to have their voices heard.
pharmaphorum
SEPTEMBER 3, 2024
Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD.Just-reported data from that study has shown that Vaxcyte's VAX-31 shot was able to stimulate a strong immune response against all 31 serotypes of Streptococcus pneumoniae included in the formulation, in adults aged 50 and over.
PharmaTech
SEPTEMBER 3, 2024
A coordinated and international response is needed to help control the latest mpox outbreak in Africa.
pharmaphorum
SEPTEMBER 3, 2024
Researchers in the Netherlands have developed 3D-printed 'mini tumours' that behave like real cancerous tissue and can be used to test new treatments, including drug and cell-based immunotherapies.The team from the Leiden Academic Centre for Drug Research say the models are an alternative to the current approach of testing immunotherapies by culturing tumour cells in a petri dish alongside T cells, or drugs such as antibodies, and seeing how they interact.
Pharmaceutical Technology
SEPTEMBER 3, 2024
RGX-121 has been evaluated in the Phase I/II/III CAMPSIITE study as a one-time gene therapy treatment for Hunter syndrome.
European Pharmaceutical Review
SEPTEMBER 3, 2024
Researchers from Sanofi Vaccines have developed an automated end-to-end process that enables real-time in-line monitoring and control of metabolites during bioprocess development. Utilising process analytical technology (PAT) and quality by design-focused principles, the metabolite feed-back control system offers an improved upstream fermentation process in stirred-tank fermentors.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmacy Times
SEPTEMBER 3, 2024
Bezisterim, an anti-inflammatory insulin sensitizer, will be authorized to proceed to a phase 2 clinical trial.
PharmaTech
SEPTEMBER 3, 2024
Bio/pharma companies should be approaching their decarbonization journey as a strategic business move for the future as industry stakeholders are placing greater value on sustainability.
Pharmacy Times
SEPTEMBER 3, 2024
Myasthenia gravis is a chronic autoimmune disease that causes muscle weakness and fatigue, with 4 main treatment options available.
PharmExec
SEPTEMBER 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
SEPTEMBER 3, 2024
Patients with DLBCL on Medicaid had worse survival outcomes than those on commercial insurance, but there were no statistically significant differences in survival between races.
PharmExec
SEPTEMBER 3, 2024
Results from the Phase III EXPLORER-LTE study found that Camzyos maintained effectiveness in treating symptomatic obstructive hypertrophic cardiomyopathy after 3.5 years of treatment.
Pharmaceutical Technology
SEPTEMBER 3, 2024
Advanz Pharma, Ocaliva’s manufacturer, said thousands of patients will no longer benefit from the treatment.
Infuse Medical
SEPTEMBER 3, 2024
In today’s rapidly evolving digital landscape, pharmaceutical sales teams face unparalleled challenges. The complexity of managing vast amounts of product information, engaging with increasingly informed healthcare professionals, and adhering to strict regulatory requirements has made traditional sales methods less effective. As a result, sales reps often struggle to deliver personalized, impactful presentations that resonate with their audience.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
321 
Let's personalize your content